Reactive oxygen species (ROS)-based
cancer treatments have attracted much attention in recent years. However, most patients respond poorly to the monotypic ROS during these treatments. In this work, a multiple ROS-based
cancer immunotherapy synergistic strategy has been developed to enhance the
therapeutic effect of
cancer. We prepare a three-dimensional
covalent organic framework (3D COF-TATB), and embed
copper ions (Cu2+) into the skeleton to obtain multifunctional nanomaterial, 3D Cu@COF-TATB. In this system,
porphyrins in 3D COF-TATB serve not only as the
photosensitizer for photodynamic process to produce
singlet oxygen(1O2), but also as the binding sites to complex with Cu2+. Cu2+ can be reduced by the GSH to generate Cu+ to produce
hydroxyl radical (•OH) through the Fenton-like reaction. Moreover, the generated multiple types of ROS induce the immunogenic cell death (ICD) of
cancer cells to improve the immunogenicity and further activate an immune response for attacking the
tumor. Combining with the immunoblocking inhibitor (aPD-1), 3D Cu@COF-TATB can effectively inhibit the
tumor growth. This work will provide a guidance for multimodal
cancer therapy in future clinical treatment settings.